![Per Grufman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Per Grufman
Chief Executive Officer at BioCrucible Ltd.
Profile
Per Grufman is currently the Chief Executive Officer at BioCrucible Ltd.
He previously worked as a Director at Karolinska Institutet, Vice President-Marine Research at Accuro Immunology AB, Vice President-Research & Development at AbSorber AB, and Vice President-Research & Development at LumiraDx Ltd.
He holds a doctorate degree from Karolinska Institutet and a graduate degree from the University of Stockholm.
Per Grufman active positions
Companies | Position | Start |
---|---|---|
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Chief Executive Officer | 19/01/2023 |
Former positions of Per Grufman
Companies | Position | End |
---|---|---|
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Karolinska Institutet | Director/Board Member | - |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | 26/11/2009 |
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | 26/11/2009 |
Training of Per Grufman
Karolinska Institutet | Doctorate Degree |
University of Stockholm | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Health Technology |
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Per Grufman